A.J. Rice

Stock Analyst at UBS

(2.23)
# 1032
Out of 5,370 analysts
271
Total ratings
58.74%
Success rate
19.30%
Average return
47 Stocks
Name Action PT Current % Upside Ratings Updated
CCRN Cross Country Health...
Maintains: Neutral
19 17
13.81 19.48% 7 May 13, 2025
AMN AMN Healthcare Servi...
Maintains: Neutral
30 26
21.9 16.44% 10 May 13, 2025
MD Pediatrix Medical Gr...
Maintains: Neutral
19 16
13.79 16.03% 17 May 12, 2025
AVAH Aveanna Healthcare H...
Maintains: Sell
5 5
4.92 1.63% 8 May 9, 2025
BXP BXP
Maintains: Neutral
80 68
72.75 -6.53% 1 May 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
90 88
78.25 12.46% 12 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
217 230
163.83 40.39% 10 Apr 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
38 40
31.78 25.87% 2 Apr 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
12 15
14.92 0.54% 11 Apr 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
5 5
3.17 29.34% 6 Feb 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 30
21.28 40.98% 4 Jan 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
40 21
15.16 38.52% 7 Jan 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
79 80
54.64 46.41% 15 Dec 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
175
152.53 14.73% 1 Nov 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
605 555
376.51 47.41% 2 Oct 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
38
23.08 64.64% 1 Oct 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
50
10.18 391.16% 1 Oct 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
247 267
170.11 56.96% 13 Aug 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
7 7
n/a n/a 2 Apr 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
10
9.91 -4.14% 2 Mar 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
250 50
n/a n/a 3 Aug 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
450 485
719.35 -32.58% 1 Aug 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
95
21.11 350.02% 13 Jul 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
311 316
368.38 -14.22% 12 Jul 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
125 96
67.73 41.74% 6 May 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
62 73
120.45 -39.39% 8 Feb 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
635 575
235.4 144.27% 9 Feb 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
38
22.27 70.63% 2 Jan 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
590 610
307.61 98.3% 12 Dec 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
308 305
263.67 15.67% 4 Nov 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
64 79
162.27 -51.32% 3 Nov 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
175 182
n/a n/a 3 Nov 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
350 410
290.3 41.23% 3 Oct 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
18
n/a n/a 1 Oct 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
43 37
7.92 367.17% 1 Aug 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
158 143
182.06 -21.45% 9 Jul 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
52 43
11.4 277.19% 7 Jul 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
36 37
n/a n/a 3 Jun 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
181 182
97.29 87.07% 5 Apr 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
181 170
n/a n/a 4 Mar 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
300 270
313.86 -13.97% 5 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
382 425
n/a n/a 7 Apr 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
1
30 -98.1% 3 Jan 25, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
4
n/a n/a 1 Jan 16, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
207 205
n/a n/a 7 Oct 31, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
58 65
n/a n/a 5 Jul 24, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
36 44
n/a n/a 2 Jan 31, 2018